Economics of Drug R&D:Financing, Strategic and Policy Considerations; Price Regulation,Capital Market Imperfections and Strategic R&D Investment Behavior in the Pharmaceutical Industry - Image 1

£65.63

VDM Verlag Economics of Drug R&D:Financing, Strategic and Policy Considerations; Price Regulation,Capital Market Imperfections and Strategic R&D Investment Behavior in the Pharmaceutical Industry

Name: Economics of Drug R&D:Financing, Strategic and Policy Considerations; Price Regulation,Capital Market Imperfections and Strategic R&D Investment Behavior in the Pharmaceutical Industry
Brand: VDM Verlag
Price: 62.94 GBP
Availability: InStock

Pharmacology

Price History & Forecast

Last 38 days • 38 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 38 days • 2 price levels

Days at Price

Current Price

Price Analysis

Most common price: £63 (23 days, 60.5%)

Price range: £63 - £66

Price levels: 2 different prices over 38 days

Description

The research is based upon my Wharton thesis, focuses on pharmaceutical R&D investment decision. It is organized into 1 theoretical chapter, 4 empirical chapters and 3 empirical appendices. Chapter2 develops a q-model framework for analyzing the determinants of pharmaceutical R&D investment. Chapters 3 and 4 test the capital market imperfections hypothesis using a variety of statistical methods. Chapter 5 builds upon this work and test the hypothesis that pharmaceutical price regulation diminishes incentives to invest in R&D. Finally, Chapter 6 employs a computer simulation model of pharmaceutical innovation and competition to study how price regulation in U.S. could affect R&D investment and innovation. Results reveal cash flows are an independent determinant of pharmaceutical R&D investment. Evidence was also uncovered suggesting pharmaceutical price regulation exerts a substantially negative influence on firm R&D investment intensity. Chapter Six obtains results consistent with those reported in Chapter Five, but given the simulation technique and investment strategy perspective numerous other results and findings were obtained.

Product Specifications

Brand: VDM Verlag
Format: Paperback
ASIN: 3639095979
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Other Branches of Medicine > Pharmacology
Domain: Amazon UK
Release Date: 15 March 2010
Listed Since: 18 March 2010

Barcode

No barcode data available

VDM Verlag Economics of Drug R&D:Financing, Strategic and Policy Considerations; Price Regulation,Capital Market Imperfections and Strategic R&D Investment Behavior in the Pharmaceutical Industry

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Springer - Innovation and Marketing in Pharmaceutical Industry

Pharmacoeconomics: From Theory to Practice

Real Options and Intellectual Property: Capital Budgeting Under Imperfect Patent Protection: 587 (Lecture Notes in Economics and Mathematical Systems, 587)

Pharmacoeconomics: From Theory to Practice

Corporate Financial Decisions and Market Value: Studies on Dividend Policy, Price Volatility, and Ownership Structure (Contributions to Management Science)

R & D, Innovation and Industrial Structure: Essays on the Theory of Technological Competition (Contributions to Economics)

Regulating Pharmaceutical Prices in India: Policy Design, Implementation and Compliance (India Studies in Business and Economics)

Regulating Pharmaceutical Prices in India: Policy Design, Implementation and Compliance (India Studies in Business and Economics)

PHARMACEUTICAL INNOVATION: Challenges & Competitors (Pharmacology-research, Safety Testing and Regulation)

Relationship between R&D and Financial Performance in Indian Pharmaceutical Industry

The Global Pharmaceutical Industry: The Demise and the Path to Recovery (Routledge Advances in Management and Business Studies)

Pharmaceutical Economics (The International Library of Critical Writings in Economics series)

Quantitative Decisions in Drug Development (Springer Series in Pharmaceutical Statistics)

Quantitative Decisions in Drug Development (Springer Series in Pharmaceutical Statistics)

Performance of Pharmaceutical Companies in India: A Critical Analysis of Industrial Structure, Firm Specific Resources, and Emerging Strategies (Contributions to Economics)

Theory of Drug Development (Chapman & Hall/CRC Biostatistics Series)

Propelling Innovation in New Drugs: Recommendations & Considerations (Pharmacology-Research, Safety Testing and Regulation)

CRC Press - Government, Big Pharma, and The People Book

Fundamentals of Drug Development

Research and Development in the Pharmaceutical Industry

Formulating and Implementing Pharmaceutical Pricing Policies: Challenges, Case Studies and Lessons Learned from Medicine Price Control

Attrition in the Pharmaceutical Industry: Reasons, Implications, and Pathways Forward

Essentials of Pharmacoeconomics: Health Economics and Outcomes Research

Wiley - Biological Drug Products: Development and Strategies